Floatz logo

Therapeutic Asset Ratings

271 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Pembrolizumab
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Roswell Park Cancer InstituteP2B (60)
Pembrolizumab
Fallopian Tube Endometrioid Adenocarcinoma
Roswell Park Cancer InstituteP2B (60)
Pembrolizumab
Recurrent Primary Peritoneal Endometrioid Adenocarcinoma
Roswell Park Cancer InstituteP2B (60)
Fludarabine
Hepatocellular Carcinoma
Roswell Park Cancer InstituteP2B (59)
Binimetinib
Colorectal Carcinoma
Roswell Park Cancer InstituteP2B (58)
Binimetinib
Exocrine Pancreatic Carcinoma
Roswell Park Cancer InstituteP2B (58)
FLUTICASONE
Gliosarcoma
Roswell Park Cancer InstituteP2B (58)
Irinotecan
Primary Peritoneal Carcinosarcoma
Roswell Park Cancer InstituteP2B (58)
Nemtabrutinib
Richter Transformation
Roswell Park Cancer InstituteP2B (58)
Palbociclib
Colorectal Carcinoma
Roswell Park Cancer InstituteP2B (58)
Sargramostim
Gliosarcoma
Roswell Park Cancer InstituteP2B (58)
(+)-VINCRISTINE
Primary Peritoneal Carcinosarcoma
Roswell Park Cancer InstituteP2B (58)
Fludarabine
Chronic Leukemia
Roswell Park Cancer InstituteP2B (57)
CIS-DIAMMINEDICHLOROPLATINUM II
Metastatic Malignant Neoplasm in the Lung
Roswell Park Cancer InstituteP1/2B (57)
CIS-DIAMMINEDICHLOROPLATINUM II
Soft Tissue Sarcoma
Roswell Park Cancer InstituteP1/2B (57)
Decitabine
Fallopian Tube Cancer
Roswell Park Cancer InstituteP2CCC (55)
Dfn-15
Melanoma
Roswell Park Cancer InstituteP2CCC (55)
Gm-Csf
Primary Peritoneal Carcinoma
Roswell Park Cancer InstituteP2CCC (55)
Nemtabrutinib
Diffuse Large B-Cell Lymphoma
Roswell Park Cancer InstituteP2CCC (55)
Montanide Isa 51
Colorectal Cancer
Roswell Park Cancer InstituteP1/2CCC (55)
Rintatolimod
Breast Cancer
Roswell Park Cancer InstituteP1/2CCC (54)
Cetuximab Sarotalocan
Non-Small Cell Lung Carcinoma
Roswell Park Cancer InstituteP2CCC (53)
Cetuximab Sarotalocan
Lung Cancer
Roswell Park Cancer InstituteP2CCC (53)
Cyclophosphamide
Hyper-IgM Syndrome Type 1
Roswell Park Cancer InstituteP2CCC (53)
Cyclophosphamide
Chronic Granulomatous Disease
Roswell Park Cancer InstituteP2CCC (53)
Showing 76 to 100 of 271 assets
PreviousPage 4 of 11Next